Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes
- 15 April 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (8) , 1147-1151
- https://doi.org/10.1016/s0002-9149(99)00049-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Aspirin as a Therapeutic Agent in Cardiovascular DiseaseCirculation, 1997
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.Circulation, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993
- Antiplatelet Agents in the Prevention and Therapy of ThrombosisAnnual Review of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983